Popular Posts

Total Downloads Worldwide

Follow by Email

Sunday, 19 May 2013

DSM-5 IS PUBLISHED SADLY!! - "A single book has come to dominate psychiatry. That is dangerous."





A single book has come to dominate psychiatry. That is dangerous
May 18th 2013

THE human brain is the most complex object in the known universe. It contains 100 billion nerve cells. Considering how complex that is, it goes wrong remarkably rarely.
But go wrong it sometimes does. Which is why, since 1952, the American Psychiatric Association has published its “Diagnostic and Statistical Manual of Mental Disorders”, the DSM. This book, the newest version of which will hit the shops on May 22nd (see article), contains the association’s thinking on what constitutes a disorder of the mind. It is consulted not only by psychiatrists, but also by insurance firms, drug companies and anxious patients and parents—not only in America, but around the world. It has become the industry standard for defining what is and is not a mental illness, and thus who gets treated, and who pays for treatment.
No other major branch of medicine has such a single text, with so much power over people’s lives. And that is worrying. Because in no other branch of medicine is the scientific reality underpinning the pronouncements of doctors so uncertain.
The categorical imperative
This uncertainty flows from a profound ignorance about how brains actually work. Neuroscientists understand how nerve cells work. They also know which bits of the brain deal with vision, locomotion, language, memory and suchlike. But between these two anatomical levels all is darkness. Psychiatrists have thus had to use behaviour patterns as proxies for underlying problems. And what constitutes a pattern is too often a matter of opinion rather than a statistically rigorous fact.
It is this desire to find and classify patterns which gives the DSM its power. By naming things it gives shape to the fledgling science. That is not a bad thing in principle. But in practice it has gone too far. The main criticisms are that it medicalises normal behaviour and that the strict categories of mental illness it creates are increasingly at odds with what research suggests is actually going on in the brain.
Both criticisms are ultimately about names. The DSM gives names like “disruptive mood dysregulation disorder” to temper tantrums in children and “binge eating disorder” to those who tend to overeat. If these were mere labels, perhaps it would not matter (though in the area of mental health even a label can be damning). But diagnosis frequently leads to prescription, and lots of pills are thus being popped by people whose need to take them is, to say the least, questionable.
The way the DSM classifies those who unquestionably are ill is also under attack. Schizophrenia, major depression and some forms of autism are disabling conditions that have long been considered separate diseases. But modern techniques of gene analysis and brain scanning are leading some researchers to wonder whether they really can be distinguished in the way that, say, various forms of leukaemia can be differentiated—for their biological underpinnings seem to overlap. Without a proper diagnosis, proper treatment is hard.
Veneration of the DSM is also harmful in research. Thomas Insel, the head of America’s National Institute of Mental Health, has publicly encouraged scientists not to be constrained by its approach, lest it prevent them finding diagnoses and treatments. In terms of diagnosis, a few psychiatrists (including those who conducted the genetics and brain-scanning studies) now publicly point to the DSM’s deficiencies; yet the DSM’s definitions and certainties are too deeply ingrained for this criticism to have hit home. The full consequences of that will not be obvious for a long time. But the current over-reliance on one point of view in this extremely uncertain science is healthy neither for psychiatry, nor for those it treats.


DSM-5 IS PUBLISHED !! - Temple Grandin on DSM-5: “Sounds like diagnosis by committee”



When it comes to autism, Grandin argues we're paying too much attention to labels -- and not enough to individuals


Excerpted from "The Autistic Brain: Thinking Across the Spectrum." This piece was written prior to the publication of the new DSM-5, but Grandin anticipated much of the thinking in the new edition.
I had my eye on Jack. He was ten years old, and he had taken only three skiing lessons in his life. I was in high school, and I’d been taking skiing lessons for three years. Yet I would watch Jack pass me on the slope, and I would see him execute these gorgeous stem christie turns, and, man, he could handle the four-foot ski jump with no problem. Meanwhile, I was still working my way up to one good christie, and every single time I tried the ski jump, I fell, until I was scared to use it.
What was so special about Jack?
Nothing, it turns out. What was so special, instead, was me — me and my autism. The connection between my autism and my poor athletic performance is pretty obvious in retrospect. At the time, though, I didn’t see it. Not until I was in my forties and I had the brain scan showing that my cerebellum — the part of the brain that helps control motor coordination — is 20 percent smaller than normal did I put two and two together. Now it all made sense! I couldn’t keep my skis together without falling because —
Because what? Because I’m autistic? Or because I have a small cerebellum?
Both answers are correct. Which, however, is more useful? That depends on what you want to know. If you’re looking for a label, something that will help you understand who I am in a general sense, then “because I’m autistic” is probably good enough. But if you’re looking for how I got that way specifically — if you’re looking for the biological source of the symptom — then the better answer is definitely “because I have a small cerebellum.”
The difference is important. It’s the difference between a diagnosis and a cause.
My research on subtypes of sensory problems got me thinking about the limitations of labels. I realized that two different labels — underresponsive to sensory input, and overresponsive to sensory input — can describe the same experience: too much information! The labels might be useful, but, as in the skiing example, their usefulness depends on what you want to know. Do you want to know what the behavior looks like from the outside? Or do you want to know what the experience feels like from the inside? Do you want a description for a set of symptoms — a diagnosis? Or do you want a source for a particular symptom — a cause?

Thursday, 16 May 2013

CANADIAN BREAKFAST TV INTERVIEW WITH PROFESSOR PETER KINDERMAN ABOUT DSM-5's PUBLICATION AND RISKS - Courtesy of CTV



http://www.ctvnews.ca/video?clipId=925925&playlistId=1.1280505&binId=1.810401&playlistPageNum=1

COMMENTS FROM OTHER MEMBERS OF THE INTERNATIONAL RESPONSE COMMITTEE TO DSM-5 - SEE:

dsm5response.com  for shared statement.



1) Wonderful performance, Peter. Pity you didn't get the chance to come back on his closing drivel but you did it nonverbally. We'll know we're really getting somewhere when people like us routinely have the last word. Definitely a good idea to try and have a conference; there is huge interest in this, there'd be no problem getting delegates.





2) Peter's point is well made, and one that has my full support. This is an exciting and stimulating group to have participated in. 
For one thing we need to keep making the point this is not a turf war or guild dispute. Our diversity as a group confirms this, and we should continue to work together to reinforce this message to those who doubt it.
Second, it's highly likely given our diversity that each us is engaged in different ways in arguing for and developing empathic, principled and context rich ways of working, some from a scientific framework, some from personal experiences of distress and recovery, others from the humanities   (e.g. Narrative and philosophy). It would an excellent idea if we could continue to share ideas as a group, for example, circulating papers we have published, talks we give, or blogs we write. Perhaps this would open up the way for even more creative fusions and cross-fertilisation of ideas.

What do others think?

WASHINGTON POST MAY 15th, 2013 - "Doctors warn new psychiatric guide could drug people who don’t need it."




http://www.washingtontimes.com/news/2013/may/15/doctors-warn-new-psychiatric-guide-could-drug-peop/


Doctors warn new psychiatric guide could drug people who don’t need it
-
The Washington Times
Wednesday, May 15, 2013
Bottom of Form
An estimated 3,000 doctors have signed a petition of protest against the psychiatric industry’s latest bible for diagnosis and treatment, the DSM-5, charging its contents could lead patients to be prescribed unnecessary medications.

The Diagnostic and Statistical Manual of Mental Disorders is set for its first update in 19 years. Its findings will be presented in San Francisco on Saturday, Bloomberg reported. The manual is hailed as the “psychiatric bible” for professionals and guides how they diagnose and treat patients; it also influences how they’re reimbursed by insurers for mental disorders, Bloomberg said.

But doctors aren’t happy with the updates — and 3,000 have signed a petition in protest.

The petition states, in part: “We, the undersigned, are concerned that the [DSM-5] includes many diagnostic categories with questionable reliability … [and] did not receive a much-needed and widely requested external scientific review [and] may compromise patient safety through the implementation of lowered diagnostic thresholds.”

Petitioners warn that the new manual “may result in the mislabeling of mental illness in people who would fare better without a psychiatric diagnosis, [and] may result in unnecessary and potentially harmful treatment with psychiatric medication.”

Bloomberg reported that the aim of the fifth edition of the DSM was to include the latest research in several conditions, such Asperger’s syndrome, which now is grouped under the autism category.

Wednesday, 15 May 2013

DSM-5 and RDoC: Slight Regression in Thinking from NMIH Due to Shared Interests - Thomas R. Insel, M.D., director, NIMH Jeffrey A. Lieberman, M.D. - President elect of the APA.



  



DSM-5 and RDoC: Shared Interests

Thomas R. Insel, M.D., director, NIMH

Jeffrey A. Lieberman, M.D., president, APA

NIMH and APA have a shared interest in ensuring that patients and health providers have the best available tools and information today to identify and treat mental health issues, while we continue to invest in improving and advancing mental disorder diagnostics for the future.


Today, the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM), along with the International Classification of Diseases (ICD) represents the best information currently available for clinical diagnosis of mental disorders. Patients, families, and insurers can be confident that effective treatments are available and that the DSM is the key resource for delivering the best available care. The National Institute of Mental Health (NIMH) has not changed its position on DSM-5. As NIMH’s Research Domain Criteria (RDoC) project website states, “The diagnostic categories represented in the DSM-IV and the International Classification of Diseases-10 (ICD-10, containing virtually identical disorder codes) remain the contemporary consensus standard for how mental disorders are diagnosed and treated.”

Yet, what may be realistically feasible today for practitioners is no longer sufficient for researchers. Looking forward, laying the groundwork for a future diagnostic system that more directly reflects modern brain science will require openness to rethinking traditional categories. It is increasingly evident that mental illness will be best understood as disorders of brain structure and function that implicate specific domains of cognition, emotion, and behavior. This is the focus of the NIMH’s Research Domain Criteria (RDoC) project. RDoC is an attempt to create a new kind of taxonomy for mental disorders by bringing the power of modern research approaches in genetics, neuroscience, and behavioral science to the problem of mental illness.


The evolution of diagnosis does not mean that mental disorders are any less real and serious than other illnesses. Indeed, the science of diagnosis has been evolving throughout medicine. For example, subtypes of cancers once defined by where they occurred in the body are now classified on the basis of their underlying genetic and molecular causes.


All medical disciplines advance through research progress in characterizing diseases and disorders. DSM-5 and RDoC represent complementary, not competing, frameworks for this goal. DSM-5, which will be released May 18, reflects the scientific progress seen since the manual’s last edition was published in 1994. RDoC is a new, comprehensive effort to redefine the research agenda for mental illness. As research findings begin to emerge from the RDoC effort, these findings may be incorporated into future DSM revisions and clinical practice guidelines. But this is a long-term undertaking. It will take years to fulfill the promise that this research effort represents for transforming the diagnosis and treatment of mental disorders.


By continuing to work together, our two organizations are committed to improving outcomes for people with some of the most disabling disorders in all of medicine.



The American Psychiatric Association is a national medical specialty society whose physician members specialize in diagnosis, treatment, prevention, and research of mental illnesses including substance use disorders. Visit the APA at www.psychiatry.org.